Kordasiewicz Holly B. 🟡 adjusted position in 60.8K shares (4 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $74.05 ($11.0M) Transaction Date: Jun 12, 2026 | Filing ID: 000208
Director BERTHELSEN SPENCER R 🟡 adjusted position in 8.0K shares (1 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $73.49 Transaction Date: Jun 15, 2026 | Filing ID: 000207
📋 Insight Venture Partners (Cayman) X, L.P. (10% Stockholder) plans to sell 601K shares of Hinge Health, Inc. (at $70.50 each, total $42.3M) Filed: Jun 16, 2026 | ID: 000246